HETEROGENEITY IN MICROVASCULAR DENSITY IN LUNG-TUMORS - COMPARISON WITH NORMAL BRONCHUS

Citation
Am. Schor et al., HETEROGENEITY IN MICROVASCULAR DENSITY IN LUNG-TUMORS - COMPARISON WITH NORMAL BRONCHUS, British Journal of Cancer, 77(6), 1998, pp. 946-951
Citations number
27
Categorie Soggetti
Oncology
Journal title
ISSN journal
00070920
Volume
77
Issue
6
Year of publication
1998
Pages
946 - 951
Database
ISI
SICI code
0007-0920(1998)77:6<946:HIMDIL>2.0.ZU;2-R
Abstract
The aim of this study was to test the hypotheses that (a) microvascula r density (MVD) measured in histological sections of resected non-smal l cell lung carcinomas is an index of angiogenesis and (b) the measure ment of MVD in a single block is representative of the overall MVD of the tumour. MVD was quantitated in one block per specimen of 60 lung t umours and nine normal lung tissues, and in 47 blocks taken from diffe rent regions of four tumours. Blood vessels were stained with antibody to von Willebrand Factor and MVD was quantitated using two methods: a verage density throughout the section (a-MVD) and density in the most vascularized area or 'hot spot' (h-MVD). Similar h-MVD values were fou nd in tumours and in normal bronchus, whereas a-MVD was greater in the latter (P < 0.01). When 47 blocks from four tumours were analysed, in ter-tumour variation was significant (P < 0.001) in spite of significa nt intra-tumour variation. The highest MVD value was not necessarily f ound in the periphery of the tumour. The four tumours were ranked into either two or four tiers according to their overall MVD. In 50 random selections of one block per tumour, the correct ranking was achieved in 68-74% of cases with the two-tier ranking and in 6-16% of cases wit h the four-tier ranking (h-MVD and a-MVD values respectively). These r esults suggest that elevated MVD values do not necessarily represent a ngiogenesis in non-small cell lung carcinomas, When only one block per tumour is examined, the chance of obtaining an accurate estimate of t he vascularity of that tumour may be lower than 68%.